Products & ServicesEvent: September 3, 2026
1000 Cures discovered a disease-modifying platform in a pill for pediatric monogenic mitochondrial diseases
Published
Signal category
Products & Services
Quote
“might have just discovered a disease-modifying platform in a pill for pediatric monogenic mitochondrial diseases”
— Ethan Perlstein|1000 Cures team
Company
- Industry
- Biotechnology Research
- Location
- Miami, US
- Company size
- 3 employees
1000 Cures is the first accelerator purpose-built for rare disease family founders, the most motivated operators in biopharma.